A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer ...

The API Innovation Center (APIIC) today released an industry white paper detailing the United States’ overreliance on foreign production of essential medicines and presenting a comprehensive plan to ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

KZN health committee chairperson Dr Imran Keeka highlights ongoing issues with medicine supply and procurement, calling for accountability from both facility and national levels.

A comprehensive assessment reveals that Sri Lanka’s pharmaceutical supply chain, though grounded in strong public access, ...

Soliman said consumers could see price increases or shortages of generic drugs in the country. There are some laws that ...

Pharmaceutical supply chains set for growth, building reliability for vaccines in developing areas and the return of a ...

Highlighting deals by PE firms pursuing investments in marketing agencies focused on pharma and life sciences; insights on a ...